[Durgical](https://durgical.com/en/) › [DurgiPedia](https://durgical.com/en/durgipedia/) › [Pharmacology](https://durgical.com/en/pharmacology/) › [Antiglaucoma agents](https://durgical.com/en/pharmacology/classes/antiglaucoma-agents/) › Netarsudil

# Netarsudil

## Antiglaucoma agents?

Antiglaucoma agents

A Rho kinase inhibitor eye drop that opens the eye's main drain (trabecular meshwork) to lower pressure in glaucoma. Red eye is common.

Updated Nov 1, 2026

## Quick facts

**Group**
[Antiglaucoma agents](https://durgical.com/en/pharmacology/classes/antiglaucoma-agents/)

**Target**
Rho-associated protein kinases (ROCK1 and ROCK2)

**Used for**
Open-angle glaucoma · Ocular hypertension

**Key effects**
Conjunctival hyperaemia · Burning · Tearing

**Monitor**
Intraocular pressure

**ATC**
S01EX05

No doses: the clinician sets them by the current guideline.

On this page

- The basics Mechanism of action
- Indications
- Adverse effects
- Pharmacokinetics
- Memory aid

- Safety Contraindications
- Key interactions
- What is monitored
- Administration and safety
- Pregnancy and breastfeeding
- Nursing care

- Study Test yourself

- Connections Connections

## Mechanism of action

Netarsudil inhibits Rho kinase, a serine-threonine kinase that controls the cytoskeleton. In the trabecular meshwork this relaxes the cells and increases conventional outflow of aqueous humour, so intraocular pressure falls. Rho kinase inhibition also dilates conjunctival vessels, which explains the frequent red eye.

- Netarsudil inhibits Rho kinase in the trabecular meshwork
- Meshwork cells relax; outflow increases
- Intraocular pressure falls

## Indications

- Open-angle glaucoma [Open-angle glaucoma →](https://durgical.com/en/conditions/open-angle-glaucoma/)
- Ocular hypertension

## Adverse effects

### Common

- Conjunctival hyperaemia (red eye), the most common effect
- Small bleeds under the conjunctiva
- Burning, stinging or pain after the drop
- Tearing, blepharitis

### Serious (rare, important)

- Whorl-like corneal deposits (cornea verticillata)
- Rare corneal epithelial oedema

## Contraindications

- Hypersensitivity to netarsudil or any component

## Key interactions

**Other eye drops**
Given at least 5 minutes apart so one does not wash out the other

## What is monitored

- Intraocular pressure
- Redness and corneal changes at eye examination

## Administration and safety

- Contact lenses come out before the drop and go back in about 15 minutes later.
- Other eye drops are spaced at least 5 minutes apart.
- Also available combined with latanoprost in one bottle; the exact product is checked.

## Pregnancy and breastfeeding

Human data are lacking; it is used in pregnancy only if the benefit justifies the risk.

## Nursing care

- Warn that red eyes are common and often settle.
- Teach to report eye pain, vision changes or eyelid infection.
- Tell the eye surgeon about netarsudil before eye surgery.

## Pharmacokinetics

**Absorption**
Acts locally in the eye

## Memory aid

«ROCK the drain»: netarsudil relaxes the trabecular meshwork; the price is a red eye.

## Test yourself

Think of the answer, then tap the question to see it.

## Which enzyme does netarsudil inhibit?

Rho kinase (ROCK).

## Through which pathway does it increase outflow?

The trabecular (conventional) outflow pathway.

## What is its most common adverse effect?

Conjunctival hyperaemia (red eye).

[Add to my cards (3)](https://durgical.app/estudiar/?add=/en/pharmacology/netarsudil/)

[More Pharmacology questions →](https://durgical.com/en/practice/?f=pharmacology)

## Connections

## Related drugs 2

- [Latanoprost](https://durgical.com/en/pharmacology/latanoprost/)
- [Timolol](https://durgical.com/en/pharmacology/timolol/)

## Related conditions 1

- [Open-angle glaucoma](https://durgical.com/en/conditions/open-angle-glaucoma/)

[← Back to the class: Antiglaucoma agents](https://durgical.com/en/pharmacology/classes/antiglaucoma-agents/)

Educational content on how drugs work; not a prescribing guide and no substitute for a health professional's advice. No doses are given.

Sources: [Netarsudil Ophthalmic: MedlinePlus Drug Information](https://medlineplus.gov/druginfo/meds/a618014.html) (MedlinePlus (U.S. National Library of Medicine), 2026); [ATCDDD - ATC/DDD Index](https://atcddd.fhi.no/atc_ddd_index/?code=S01EX05) (WHO Collaborating Centre for Drug Statistics Methodology, 2026).

## **Spotted a mistake?** We are always improving for the community. Tell us what is wrong and our team will review it. Report a mistake

Representative model, for educational purposes only.

---
Source: https://durgical.com/en/pharmacology/netarsudil/
License: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Cite as: DurgiPedia (durgical.com), https://durgical.com/en/pharmacology/netarsudil/